Fresenius Medical Care AG (FMS)
20.88
+0.20
(+0.97%)
USD |
NYSE |
May 09, 16:00
21.84
+0.96
(+4.60%)
Pre-Market: 09:08
Fresenius Medical Care Price to Book Value: 0.8159 for May 9, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 0.8159 |
| May 08, 2024 | 0.808 |
| May 07, 2024 | 0.7858 |
| May 06, 2024 | 0.837 |
| May 03, 2024 | 0.8194 |
| May 02, 2024 | 0.8463 |
| May 01, 2024 | 0.8291 |
| April 30, 2024 | 0.8221 |
| April 29, 2024 | 0.8092 |
| April 26, 2024 | 0.7854 |
| April 25, 2024 | 0.7897 |
| April 24, 2024 | 0.8112 |
| April 23, 2024 | 0.8393 |
| April 22, 2024 | 0.803 |
| April 19, 2024 | 0.7635 |
| April 18, 2024 | 0.7576 |
| April 17, 2024 | 0.7412 |
| April 16, 2024 | 0.7268 |
| April 15, 2024 | 0.7334 |
| April 12, 2024 | 0.7186 |
| April 11, 2024 | 0.7397 |
| April 10, 2024 | 0.7455 |
| April 09, 2024 | 0.7518 |
| April 08, 2024 | 0.7385 |
| April 05, 2024 | 0.7326 |
| Date | Value |
|---|---|
| April 04, 2024 | 0.7318 |
| April 03, 2024 | 0.7358 |
| April 02, 2024 | 0.7334 |
| April 01, 2024 | 0.7459 |
| March 31, 2024 | |
| March 28, 2024 | 0.7515 |
| March 27, 2024 | 0.7546 |
| March 26, 2024 | 0.737 |
| March 25, 2024 | 0.7374 |
| March 22, 2024 | 0.7304 |
| March 21, 2024 | 0.7429 |
| March 20, 2024 | 0.7663 |
| March 19, 2024 | 0.7612 |
| March 18, 2024 | 0.7417 |
| March 15, 2024 | 0.7421 |
| March 14, 2024 | 0.7651 |
| March 13, 2024 | 0.7827 |
| March 12, 2024 | 0.7846 |
| March 11, 2024 | 0.7823 |
| March 08, 2024 | 0.7932 |
| March 07, 2024 | 0.8049 |
| March 06, 2024 | 0.7815 |
| March 05, 2024 | 0.8092 |
| March 04, 2024 | 0.7277 |
| March 01, 2024 | 0.7546 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5081
Minimum
Oct 10 2022
2.080
Maximum
Jul 29 2020
1.300
Average
1.406
Median
Nov 01 2021
Price to Book Value Benchmarks
| Biodexa Pharmaceuticals Plc | 0.7356 |
| NuCana PLC | 0.3902 |
| TC BioPharm (Holdings) PLC | 1.149 |
| DaVita Inc | 13.06 |
| Bicycle Therapeutics PLC | 2.519 |
Price to Book Value Related Metrics
| PE Ratio | 23.34 |
| PS Ratio | 0.5796 |
| Price to Free Cash Flow | 5.843 |
| Price | 20.88 |
| Earnings Yield | 4.28% |
| Market Cap | 12.25B |
| Operating PE Ratio | 6.836 |
| Normalized PE Ratio | 18.02 |